David graduated from the University of Michigan with a degree in Computer Science, David volunteered in different labs at Caltech working on projects that bridged neuroscience and artificial intelligence. Prior to beginning his PhD. David held a position at the Jet Propulsion Laboratory's Artificial Intelligence group. David received his PhD. in September 2021.
During his graduate work, he worked to develop a method to better understand the cell types in the brain that get targeted by AAV-based gene therapy delivery (https://www.biorxiv.org/content/10.1101/2021.06.25.449955v2), as well as technology to expand the scope of people that can benefit from single-cell transcriptome sequencing by scaling it down to small volumes of self-collected blood (https://www.nature.com/articles/s41598-020-77073-3).
After graduating, he co-founded ImYoo (https://imyoo.health), a start-up focused on bringing single-cell sequencing to people with chronic immune conditions in an effort to establish the high-dimensional, large-scale data needed to make more personalized medicine.